Pulse 110/min beats per min + 20 Systolic blood pressure <100 mmhg Respiratory rate 30 breaths per min + 20

Similar documents
Are there still any valid indications for thrombophilia screening in DVT?

Intravenous Infusions

UKMEC SUMMARY TABLE HORMONAL AND INTRAUTERINE CONTRACEPTION

Hematologic Disorders. Assistant professor of anesthesia

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

What is the appropriate evaluation of cryptogenic stroke, and when is a hypercoagulability work-up needed? David E. Thaler, MD, PhD, FAHA

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4

THROMBOSIS RISK FACTOR ASSESSMENT

GENERAL SURGICAL ADULT POST-OPERATIVE ORDERS 1 of 4

Potpourri of Hematology Oncology. Jasmine Nabi, M.D. Oncology Associates Hall-Perrine Cancer Center at Mercy

Mabel Labrada, MD Miami VA Medical Center

ICD-10 Physician Education. Palliative Care SIP

Acute Arrhythmias in the Hospitalized Patient

ADULT CARDIAC SURGERY TELEMETRY BED TRANSFER ORDERS 1 of 4

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018

Sinus and Cerebral Vein Thrombosis

Objectives: This presentation will help you to:

Clinical Problem. Management. Discussion

Resuscitation Before Emergency Surgeries FEIRAN LOU SUNY DOWNSTATE MEDICAL CENTER KINGS COUNTY HOSPITAL

Is Thrombolysis Only for a Crisis?

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

Inventory of paediatric therapeutic needs

4. Which survey program does your facility use to get your program designated by the state?

Heart Failure (HF) Treatment

Case year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50

Information Often Given to the Nurse at the Time of Admission to the Postanesthesia Care Unit

Duration of Anticoagulant Therapy. Linda R. Kelly PharmD, PhC, CACP September 17, 2016

Atrial fibrillation in the ICU

Thrombosis. By Dr. Sara Mohamed Abuelgasim

Thrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI

Index. Note: Page numbers of article titles are in boldface type.

Pulmonary Embolectomy:

Adult Critical Care Intravenous Infusions Titration Protocol

Approach to Thrombosis

Thrombophilia. Dr. A Sarrafnejad PhD Dep. Immunology School of public health TUMS

Medical Management of Acute Heart Failure

Hemostasis. PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

PERSONAL CHARACTERISTICS AND REPRODUCTIVE HISTORY...3 Pregnancy...3 Age...3 Parity...3 Breastfeeding...3 Postpartum...3 Post-abortion...

Medical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011

OBSTETRIC ADMISSION ORDERS 1 of 4

Index. Note: Page numbers of article titles are in boldface type.

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

LeMone & Burke Ch 30-32

Guidelines for management of stroke in childhood

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

Index. Note: Page numbers of article titles are in boldface type.

Scott M. Stevens, MD. Co-Director, Thrombosis Clinic. Associate Professor of Clinical Medicine

TELEMETRY/STEPDOWN UNIT SKILLS CHECKLIST

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

The Multi-Factorial Threshold Model of Thrombotic Risk

Adenosine. poison/drug induced. flushing, chest pain, transient asystole. Precautions: tachycardia. fibrillation, atrial flutter. Indications: or VT

Jeopardy Tip Sheets. 12 Lead EKG Review. Leads affected. Coronary artery involved. Area of myocardium INFERIOR RCA II, III, AVF SEPTAL LAD V1 & V2

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

Chapter 26. Media Directory. Dysrhythmias. Diagnosis/Treatment of Dysrhythmias. Frequency in Population Difficult to Predict

ΚΟΛΠΙΚΗ ΜΑΡΜΑΡΥΓΗ ΦΑΡΜΑΚΕΥΤΙΚΗ ΗΛΕΚΤΡΙΚΗ ΑΝΑΤΑΞΗ. ΣΠΥΡΟΜΗΤΡΟΣ ΓΕΩΡΓΙΟΣ Καρδιολόγος, Ε/Α, Γ.Ν.Κατερίνης. F.E.S.C

Index. Note: Page numbers of article titles are in boldface type.

HOW LOW CAN YOU GO? HYPOTENSION AND THE ANESTHETIZED PATIENT.

INHERITED COAGULOPATHY

ADVANCED THERAPIES FOR PHARMACOLOGICAL TREATMENT OF PULMONARY HYPERTENSION

Treatment of Arrhythmias in the Emergency Setting

Thrombophilia: To test or not to test

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

CRITICAL CARE/INTENSIVE CARE SKILLS CHECKLIST

ACUTE KIDNEY INJURY (AKI) ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ADVANCED DIRECTIVE LIMITING CARE...91 AGE...9 AGE UNITS...

Management of Heart Failure and Cardiomyopathies in Pregnancy

Thursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III

IFT1 Interfacility Transfer of STEMI Patients. IFT2 Interfacility Transfer of Intubated Patients. IFT3 Interfacility Transfer of Stroke Patients

Unit 4 Problems of Cardiac Output and Tissue Perfusion

ACUTE HEART FAILURE. Julie Gorchynski MD, MSc, FACEP, FAAEM. Department of Emergency Medicine Emergency Residency Program UTHSC, San Antonio TCEP 2014

Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification

Titrating Critical Care Medications

From Bench to Bedside: Reducing Sepsis Mortality

DIAGNOSIS AND MANAGEMENT OF ACUTE HEART FAILURE

The Pharmacology of Hypotension: Vasopressor Choices for HIE patients. Keliana O Mara, PharmD August 4, 2018

Low-Molecular-Weight Heparin

Venous Thromboembolism. Prevention

A study of clinical profile of 50 patients deep venous thrombosis at general hospital

Cardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center

Use of Antiarrhythmic Drugs for AF Who, What and How? Dr. Marc Cheng Queen Elizabeth Hospital

Physiological Measurements Training for Care/Nursing & LD Small Group Home Staff

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

Venothromboembolism prophylaxis: Trauma and Orthopaedics Clinical guideline, V2

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Percutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI

Mr. Eknath Kole M.S. Pharm (NIPER Mohali)

Episodes of Care Risk Adjustment

Updates in Diagnosis & Management of VTE

Supplementary Appendix

Pulmonary Thromboembolism

Interventional Treatment VTE: Radiologic Approach

Cor pulmonale. Dr hamid reza javadi

ACTIVITY DISCLAIMER DISCLOSURE. Craig Barstow, MD, FAAFP. Learning Objectives. Associated Session(s) Arrhythmias and Dysrhythmias: PBL

ANTI-ARRHYTHMICS AND WARFARIN. Dr Nithish Jayakumar

I have nothing to disclose.

1 Week Followup - Intermacs

2. To provide an ethical, moral and practical framework for decision-making during a public health emergency.

Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview

Transcription:

Online Supplement Impact of Relative Contraindications to Home Management in Emergency Department Patients with Low-Risk Pulmonary Embolism David R. Vinson, Carrieann E. Drenten, Jie Huang, J. Eileen Morley, Megan L. Anderson, Mary E. Reed, Daniel K. Nishijima, and Vincent Liu; on behalf of the KP CREST Network Table E1. The Pulmonary Embolism Severity Index Predictors Points* Demographic Characteristics Age + 1 per year Male sex + 10 Comorbid Illness Cancer (active or history of) + 30 Heart Failure (systolic or diastolic) + 10 Chronic Lung Disease (includes asthma) + 10 Clinical Findings Pulse 110/min beats per min + 20 Systolic blood pressure <100 mmhg + 30 Respiratory rate 30 breaths per min + 20 Temperature <36 C + 20 Altered mental status + 60 Arterial oxygen saturation <90% + 20 * A total point score for a given patient is obtained by summing the patient's age in years and the points for each applicable characteristic. Point scores correspond with the following classes that estimate escalating risks of 30-day mortality: 65 class I, very low risk; 66-85 class II, low risk; 86-105 class III, intermediate risk; 106-125 class IV, high risk; >125 class V, very high risk. The worst vital signs are used Acute or pre-existing disorientation, lethargy, stupor, or coma With or without supplemental oxygenation

E2 Table E2. Programming used to facilitate investigator identification of 5-day and 30-day adverse outcomes in emergency department patients with acute pulmonary embolism Variable Programming source Definition Thrombolysis CLARITY ORDER_PROC CPT codes: 37211-37214 Thrombectomy CLARITY ORDER_PROC CPT codes: 37184-37188 Respiratory support Cardiac dysrhythmia with treatment Reception of vasopressors or inotropic medications Anatomically-defined major hemorrhage Non-specific bleeding diagnoses Nursing flowsheet CLARITY IP_FLWSHT_REC CLARITY IP_FLWSHT_MEAS Any inpatient diagnosis CLARITY Medication list ORDER_MED Medication list ORDER_MED Any emergency department or inpatient diagnosis CLARITY PAT_ENC_DX Any emergency department diagnosis or a primary inpatient diagnosis CLARITY PAT_ENC_DX Non-rebreather mask, bilevel positive airway pressure, continuous positive airway pressure, ventilator ICD-9 codes: 427.31, 427.32, 427.0, 427.2, 427.1, 427.41, 427.42, 427.5 Intravenous amiodarone, procainamide, lidocaine, adenosine, ibutilide, vernakalant, digoxin, diltiazem, verapamil, esmolol, metoprolol, propranolol Intravenous dopamine, norepinephrine, epinephrine, dobutamine, milrinone, phenylephrine, vasopressin, isoproterenol ICD-9 codes: 430, 431, 432.0, 432.1, 432.9, 9, 852.00, 852.01, 852.02, 852.03, 852.04, 852.05, 852.06, 852.09, 852.10, 852.11, 852.12, 852.13, 852.14, 852.15, 852.16, 852.19, 852.20, 852.21, 852.22, 852.23, 852.24, 852.25, 852.26, 852.29, 852.30, 852.31, 852.32, 852.33, 852.34, 852.35, 852.36, 852.39, 852.40, 852.41, 852.42, 852.43, 852.44, 852.45, 852.46, 852.49, 852.50, 852.51, 852.52, 852.53, 852.54, 852.55, 852.56, 852.59, 853.00, 853.01, 853.02, 853.03, 853.04, 853.05, 853.06, 853.09, 853.10, 853.11, 853.12, 853.13, 853.14, 853.15, 853.16, 853.19, 336.1, 360.43, 459.0, 719.10, 719.11, 719.12, 719.13, 719.14, 719.15, 719.16, 719.17, 719.18, 719.19, 423.0, 423.3, 958.90-958.99, 729.71-729.79 ICD-9 codes: 456.8, 580.9, 596.7, 596.8, 599.70, 599.71, 626.2, 626.6, 626.8, 455.2, 455.5, 455.8, 456.0, 456.2, 459.0, 530.21, 530.7, 530.82, 531.00, 531.01, 531.10, 531.11, 531.20, 531.21, 531.30, 531.31, 531.40, 531.41, 531.50, 531.51, 531.60, 531.61, 531.70, 531.71, 531.90, 531.91, 532.00, 532.01, 532.10, 532.11, 532.20, 532.21, 532.30, 532.31, 532.40, 532.41, 532.50, 532.51, 532.60, 532.61, 532.70, 532.71, 532.90, 532.91, 533.00, 533.01, 533.10, 533.11, 533.20, 533.21, 533.30, 533.31, 533.40, 533.41, 533.50, 533.51, 533.60, 533.61, 533.70, 533.71, 533.90, 533.91, 534.00, 534.01, 534.10, 534.11, 534.20, 534.21,

E3 Red blood transfusions Anemia Diagnostic imaging for possible recurrent venous thromboembolic disease Nursing flowsheet IP_FLWSHT_REC IP_FLWSHT_MEAS ORDER_PROC 534.30, 534.31, 534.40, 534.41, 534.50, 534.51, 534.60, 534.61, 534.70, 534.71, 534.90, 534.91, 535.00, 535.01, 535.10, 535.11, 535.20, 535.21, 535.30, 535.31, 535.40, 535.41, 535.50, 535.51, 535.60, 535.61, 535.70, 535.71, 537.82, 537.83, 537.84, 537.89, 562.02, 562.03, 562.12, 562.13, 568.81, 569.3, 569.69, 569.84, 569.85, 577.8, 578.0, 578.1, 578.9, 562.02, 255.41, 784.7, 784.8, 785.59, 786.3 Report dates of transfusion Report dates on which the serum hemoglobin ORDER_RESULTS value was <9 gm/dl ORDER_PROC CPT codes: 71275, 71260, 71270, 78579, 78580, 78582, 78584, 78585, 78586, 78587, 78588, 78591, 78593, 78594, 75743, 75746, 71555, 93970, 93971 CPT, Current Procedural Terminology; ICD-9, International Classification of Disease, Ninth edition

E4 Table E3. Risk factors for venous thromboembolism among emergency department patients with acute pulmonary embolism who are low risk on the Pulmonary Embolism Severity Index Venous Thromboembolism Risk Factor N=423 No (%) Body mass index (BMI) 30; or if BMI not 229 (54.1) reported, weight 120 kg Hospitalization overnight (within the prior 3 months) 86 (20.3) History of prior venous thromboembolism 75 (17.7) Surgery (within the prior 3 months) 74 (17.5) Bed rest, immobilization (e.g., cast), or paresis/paralysis beyond 48 hours in duration (within the prior month) 62 (14.7) Estrogen use (excluding vaginal application) 54 (12.8) Long ground or air travel beyond four hours in duration or air travel beyond 1500 miles (within the prior month) Smoking, active or recent quit (within the prior month) 47 (11.1) 40 (9.5) Auto-immune disease* 22 (5.2) Non-minimal trauma (within the prior 3 months) 19 (4.5) Inherited hypercoagulable state 12 (2.8) Heart failure 10 (2.4) Post-partum, post-miscarriage, post-ectopic pregnancy, or post-abortion (within the prior 6 weeks) 9 (2.1) Cancer, known or history 9 (2.1) Chronic obstructive lung disease 8 (1.9) Nephrotic syndrome 4 (0.9) Central venous catheterization (within the prior 3 months) 4 (0.9) Pregnancy 3 (0.7) Medical condition with hyperviscosity 2 (0.5) Acute sepsis diagnosis 2 (0.5)

E5 Acute stroke diagnosis 0 Human immunodeficiency virus 0 * Includes Crohn s disease (regional enteritis), ulcerative colitis, rheumatoid arthritis, systemic lupus erythematosus, Behcet disease, immune thrombocytopenic purpura, polymyositis, dermatomyositis, and polyarteritis nodosa Includes factor V Leiden deficiency, prothrombin gene mutation, antithrombin III deficiency, protein C or S deficiency, factor XIII mutation, familial dysfibrinogenemia, and antiphospholipid syndrome (lupus anticoagulant, anti-cardiolipin antibodies, anti-β2-glycoprotein 1 antibodies) Includes polycythemia, multiple myeloma, essential thrombocytosis, sickle cell anemia, paroxysmal nocturnal hemoglobinuria, and heparin-induced thrombocytopenia